Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial.
Hilmi M, Kamal M, Vacher S, Dupain C, Ibadioune S, Halladjian M, Sablin MP, Marret G, Ajgal ZC, Nijnikoff M, Salomon A, El Beaino Z, Servant N, Dureau S, Sokol H, Nicolle R, Le Tourneau C, Bieche I, Neuzillet C. Hilmi M, et al. Among authors: sablin mp. Eur J Cancer. 2023 Apr;183:152-161. doi: 10.1016/j.ejca.2023.01.024. Epub 2023 Feb 8. Eur J Cancer. 2023. PMID: 36868056
Changes in tumor density in patients with advanced hepatocellular carcinoma treated with sunitinib.
Faivre S, Zappa M, Vilgrain V, Boucher E, Douillard JY, Lim HY, Kim JS, Im SA, Kang YK, Bouattour M, Dokmak S, Dreyer C, Sablin MP, Serrate C, Cheng AL, Lanzalone S, Lin X, Lechuga MJ, Raymond E. Faivre S, et al. Among authors: sablin mp. Clin Cancer Res. 2011 Jul 1;17(13):4504-12. doi: 10.1158/1078-0432.CCR-10-1708. Epub 2011 Apr 29. Clin Cancer Res. 2011. PMID: 21531821 Clinical Trial.
[PI3K-AKT-mTOR pathway and cancer].
Coutte L, Dreyer C, Sablin MP, Faivre S, Raymond E. Coutte L, et al. Among authors: sablin mp. Bull Cancer. 2012 Feb 1;99(2):173-80. doi: 10.1684/bdc.2011.1384. Bull Cancer. 2012. PMID: 21742593 Free article. Review. French.
[Targeted therapies in colorectal cancer].
Sablin MP, Dreyer C, Colichi C, Bouattour M, Faivre S. Sablin MP, et al. Rev Prat. 2010 Oct 20;60(8):1094-9. Rev Prat. 2010. PMID: 21197741 French.
Pembrolizumab for Early Triple-Negative Breast Cancer.
Schmid P, Cortes J, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Foukakis T, Fasching PA, Cardoso F, Untch M, Jia L, Karantza V, Zhao J, Aktan G, Dent R, O'Shaughnessy J; KEYNOTE-522 Investigators. Schmid P, et al. N Engl J Med. 2020 Feb 27;382(9):810-821. doi: 10.1056/NEJMoa1910549. N Engl J Med. 2020. PMID: 32101663 Clinical Trial.
Sequential sorafenib and sunitinib for renal cell carcinoma.
Sablin MP, Negrier S, Ravaud A, Oudard S, Balleyguier C, Gautier J, Celier C, Medioni J, Escudier B. Sablin MP, et al. J Urol. 2009 Jul;182(1):29-34; discussion 34. doi: 10.1016/j.juro.2009.02.119. Epub 2009 May 17. J Urol. 2009. PMID: 19447417
Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
Bonsang-Kitzis H, Chaltier L, Belin L, Savignoni A, Rouzier R, Hamy AS, Sablin MP, Lerebours F, Bidard FC, Cottu P, Sastre-Garau X, Laé M, Pierga JY, Reyal F. Bonsang-Kitzis H, et al. Among authors: sablin mp. PLoS One. 2016 Jul 7;11(7):e0159123. doi: 10.1371/journal.pone.0159123. eCollection 2016. PLoS One. 2016. PMID: 27388624 Free PMC article.
[Irinotecan and liver dysfunctions].
Sablin MP, Le Tourneau C, Faivre S, Raymond E. Sablin MP, et al. Therapie. 2007 Mar-Apr;62(2):111-5. doi: 10.2515/therapie:2007024. Epub 2007 Jun 21. Therapie. 2007. PMID: 17582311 French.
61 results